Zacks Investment Research on MSN
Pfizer Inc. (PFE) is a trending stock: Facts to know before betting on it
Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...
Pfizer Inc. (NYSE:PFE) is included among the Dividend Champions, Contenders, and Challengers List: 15 Highest Yielding Stocks. Pfizer Inc. (NYSE:PFE) reported its Q4 2025 results on February 3. The ...
Pfizer Inc. (NYSE:PFE) is included among the 14 Best Dividend Stocks to Invest in Under $50. On March 2, Argus upgraded ...
The company incurred a loss in its most recent quarterly results.
Those were in great demand at the beginning of the pandemic, and generated gobs of money for Pfizer. Demand has waned, though ...
Pfizer Inc. (NYSE:PFE) is one of the most promising low-cost stocks to buy now. On February 10, Bernstein maintained its Market Perform rating and $30 price target for Pfizer following a Q4 2o25 ...
Historical patterns indicate that abrupt fluctuations in the market can impact any firm, regardless of its seeming dominance.
Pfizer Inc. (NYSE:PFE) is among the 13 Most Undervalued S&P 500 Stocks to Invest In. On February 27, 2026, Pfizer Inc.
The general mood among these heavyweight investors is divided, with 44% leaning bullish and 55% bearish. Among these notable options, 6 are puts, totaling $448,868, and 3 are calls, amounting to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results